STOCK TITAN
  1. Home
  2. Sec-filings
  3. NUWE
  4. [EFFECT] Nuwellis, Inc. SEC Filing

[EFFECT] Nuwellis, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 9, 2026 5:00 P.M.
Form: S-3
CIK: 0001506492
Company Name: Nuwellis, Inc.
File Number: 333-293181

Source: View Original Filing on SEC EDGAR

Stock NUWE logo
Nuwellis Inc

NASDAQ:NUWE

NUWE Rankings

#6922 Ranked by Market Cap
N/A Ranked by Dividends

NUWE Latest News

Jan 30, 2026
Nuwellis Appoints Carisa Schultz as Chief Financial Officer
Jan 29, 2026
Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market
Jan 29, 2026
Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy
Jan 23, 2026
Nuwellis Announces Changes to Board of Directors
Jan 6, 2026
Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy

NUWE Latest SEC Filings

Feb 12, 2026
[Form 3] Nuwellis, Inc. Initial Statement of Beneficial Ownership
Feb 11, 2026
[Form 3] Nuwellis, Inc. Initial Statement of Beneficial Ownership
Feb 11, 2026
[Form 3] Nuwellis, Inc. Initial Statement of Beneficial Ownership
Feb 9, 2026
[424B3] Nuwellis, Inc. Prospectus Filed Pursuant to Rule 424(b)(3)
Feb 3, 2026
[S-3] Nuwellis, Inc. Shelf Registration Statement

NUWE Stock Data

1.78M
1.69M
2.92%
1.49%
2.45%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
EDEN PRAIRIE